New CEO Plans ‘Transformation’ For Jubilant Generics

Follows A Poor Q1 And Further FDA Observations After Roorkee Import Alert

 
• By Dave Wallace
  
Caterpillar to butterfly transformation
Jubilant is hoping to transform its fortunes with new leadership • Source: Shutterstock

More from Leadership

More from Generics Bulletin